onyda xr

Generic: clonidine hydrochloride

Labeler: nextwave pharmaceuticals, inc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name onyda xr
Generic Name clonidine hydrochloride
Labeler nextwave pharmaceuticals, inc
Dosage Form SUSPENSION, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

clonidine hydrochloride .1 mg/mL

Manufacturer
NextWave Pharmaceuticals, Inc

Identifiers & Regulatory

Product NDC 24478-148
Product ID 24478-148_00de799f-c9cb-42b7-8471-5bde35108200
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA217645
Listing Expiration 2026-12-31
Marketing Start 2024-08-13

Pharmacologic Class

Classes
adrenergic alpha2-agonists [moa] central alpha-2 adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 24478148
Hyphenated Format 24478-148

Supplemental Identifiers

RxCUI
2690727 2690735
UPC
0324478148010 0324478148034
UNII
W76I6XXF06

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name onyda xr (source: ndc)
Generic Name clonidine hydrochloride (source: ndc)
Application Number NDA217645 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .1 mg/mL
source: ndc
Packaging
  • 7 mL in 1 BOTTLE (24478-148-01)
  • 30 mL in 1 BOTTLE (24478-148-03)
source: ndc

Packages (2)

24478-148-01 7 mL in 1 BOTTLE (24478-148-01) 24478-148-03 30 mL in 1 BOTTLE (24478-148-03)

Ingredients (1)

clonidine hydrochloride (.1 mg/mL)

Linked Drug Pages (1)

ONYDA XR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "00de799f-c9cb-42b7-8471-5bde35108200", "openfda": {"upc": ["0324478148010", "0324478148034"], "unii": ["W76I6XXF06"], "rxcui": ["2690727", "2690735"], "spl_set_id": ["4a15c850-9da5-4bdc-a34d-7f740a6149b7"], "manufacturer_name": ["NextWave Pharmaceuticals, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "7 mL in 1 BOTTLE (24478-148-01)", "package_ndc": "24478-148-01", "marketing_start_date": "20240813"}, {"sample": false, "description": "30 mL in 1 BOTTLE (24478-148-03)", "package_ndc": "24478-148-03", "marketing_start_date": "20240813"}], "brand_name": "ONYDA XR", "product_id": "24478-148_00de799f-c9cb-42b7-8471-5bde35108200", "dosage_form": "SUSPENSION, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "24478-148", "generic_name": "Clonidine hydrochloride", "labeler_name": "NextWave Pharmaceuticals, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ONYDA XR", "active_ingredients": [{"name": "CLONIDINE HYDROCHLORIDE", "strength": ".1 mg/mL"}], "application_number": "NDA217645", "marketing_category": "NDA", "marketing_start_date": "20240813", "listing_expiration_date": "20261231"}